Lucid Diagnostics Inc.
HealthcareNASDAQ:LUCD · NASDAQ Global Market
-$0.02 today
Vol 0.83M · Avg 0.83M
Cash Flow
Check whether earnings turn into cash
Use operating cash flow, capital spending, free cash flow, and financing activity to see how much value is left for reinvestment or owners.
Free Cash Flow
Net Income to FCF bridge
Analysis
Analysis will appear once cash flow data is available for this period.
Cash Flow Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$58.0M -27.4% | -$45.5M +13.6% | -$52.7M +6.2% | -$56.2M -100.1% | -$28.1M | $487.6M | $476.4M | $465.2M |
| Depreciation & Amortization | $872.0K -25.3% | $1.2M -53.3% | $2.5M +29.1% | $1.9M +48300.0% | $4.0K | $374.2M | $1.2B | $631.8M |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $1.4B | -$1.5B | $304.2M |
| Stock-Based Compensation | $4.5M -0.9% | $4.5M -33.5% | $6.8M -54.5% | $15.0M +56.2% | $9.6M | $489.0M | $354.6M | -$1.6B |
| Change in Working Capital | -$2.8M +36.7% | -$4.4M -178.1% | $5.7M -36.3% | $8.9M +1003.6% | $807.0K | $350.4M | -$1.6B | $1.5B |
| Accounts Receivables | -$601.0K | $0 +100.0% | -$28.0K -115.3% | $183.0K +191.5% | -$200.0K | $592.6M | $1.3B | $626.2M |
| Inventory | $0 | $0 | $0 | $0 | $0 | $1.0B | $1.2B | $1.1B |
| Accounts Payables | -$270.0K -381.3% | $96.0K +7.9% | $89.0K +120.0% | -$445.0K +33.1% | -$665.0K | $948.2M | -$1.5B | $433.0M |
| Other Working Capital | -$1.9M +57.3% | -$4.5M -180.6% | $5.6M -38.8% | $9.2M +448.3% | $1.7M | $567.4M | $1.3B | $601.0M |
| Other Non-Cash Items | $9.0M +7436.1% | $119.0K -97.5% | $4.9M +643.2% | $653.0K | $0 | $1.4B | -$1.5B | $300.0M |
| Operating Cash Flow | -$46.5M -5.3% | -$44.1M -34.5% | -$32.8M -10.6% | -$29.7M -68.0% | -$17.7M | $7.2B | $8.9B | $10.5B |
| Capital Expenditures | -$197.0K +69.5% | -$646.0K -192.3% | -$221.0K +75.7% | -$908.0K -5.3% | -$862.0K | $664.0M | $1.4B | $697.6M |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 | $937.0M | $1.1B | $1.3B |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $444.2M | $1.4B | $1.3B |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $822.2M | $318.2M | -$1.5B |
| Other Investing Activities | $0 +100.0% | -$350.0K | $0 +100.0% | -$3.2M | $0 | $616.4M | $370.0M | $1.2B |
| Investing Cash Flow | -$197.0K +69.5% | -$646.0K -192.3% | -$221.0K +94.6% | -$4.1M -376.6% | -$862.0K | $4.8B | $6.4B | $5.1B |
| Debt Repayment | $360.0K -98.0% | $18.0M +80.0% | $10.0M | $0 | $0 | $680.8M | $759.2M | $1.1B |
| Common Stock Issued | $58.7M | $0 -100.0% | $284.0K -84.3% | $1.8M -97.7% | $77.7M | $778.8M | $946.8M | $812.4M |
| Common Stock Repurchased | $0 | $0 | $0 | $0 | $0 | $351.8M | -$1.6B | $1.5B |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $535.2M | $613.6M | $692.0M |
| Other Financing Activities | $0 -100.0% | $451.0K -18.1% | $551.0K -31.5% | $804.0K +114.2% | -$5.7M | -$1.6B | $1.3B | $1.1B |
| Financing Cash Flow | $59.0M +22.3% | $48.2M +63.8% | $29.5M +1028.3% | $2.6M -96.4% | $72.1M | $12.2B | $13.9B | -$15.5B |
| Effect of Forex Changes | $0 | $0 | $0 | $0 +100.0% | -$255 | $1.3B | $1.1B | $990.2M |
| Net Change in Cash | $12.3M +256.6% | $3.5M +196.8% | -$3.6M +88.5% | -$31.2M -158.2% | $53.5M | $3.2B | $4.9B | $6.5B |
| Free Cash Flow | -$46.5M -3.8% | -$44.8M -35.6% | -$33.0M -8.0% | -$30.6M -65.1% | -$18.5M | $8.6B | -$16.8B | $11.1B |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Anteris Technologies Global Corp.
NASDAQ:AVR
$336.61M
Opus Genetics, Inc.
NASDAQ:IRD
$328.84M
Apyx Medical Corporation
NASDAQ:APYX
$196.39M
AVITA Medical, Inc.
NASDAQ:RCEL
$97.14M
Seer, Inc.
NASDAQ:SEER
$94.57M
Owlet, Inc.
NYSE:OWLT
$84.14M
Rapid Micro Biosystems, Inc.
NASDAQ:RPID
$79.77M
Scilex Holding Company
NASDAQ:SCLX
$72.18M
SkyAI, Inc.
STSS
$47.61M
Incannex Healthcare Limited
IXHL
$43.99M
SEC Filings
Recent regulatory filings
No filings found.
Does LUCD generate free cash flow?
Lucid Diagnostics Inc. (LUCD) generated -$46,485,000.00 of free cash flow in fiscal 2025.
How much operating cash flow does LUCD produce?
Operating cash flow was -$46,485,000.00, before capital expenditures of $197,000.00.
Explore More
Continue the stock analysis
Jump to another research area for this company.